NedraParker,
Hi and welcome to the site. Everyone here is so kind and helpful. I have/had DLBCL and had treatments of rchop chemo. I’ve been in remission for 5 yrs. I hope you have a relaxing day. Kelly
April 2
What are the survival outcomes and prognosis for aggressive stage peripheral T-cell lymphoma NOS?
Peripheral T-cell lymphoma (PTCL) is an aggressive form of non-Hodgkin lymphoma. Overall, people with T-cell NHL have a five-year survival rate of about 63 percent, which is slightly lower than the general NHL survival rate.
Show Full Answer
What are the survival outcomes and prognosis for aggressive stage peripheral T-cell lymphoma NOS?
Peripheral T-cell lymphoma (PTCL) is an aggressive form of non-Hodgkin lymphoma. Overall, people with T-cell NHL have a five-year survival rate of about 63 percent, which is slightly lower than the general NHL survival rate.
Several factors influence prognosis for aggressive T-cell lymphomas:
* Stage at diagnosis - Earlier stages typically have better outcomes than advanced stages
* International Prognostic Index (IPI) score - Higher risk scores may indicate poorer outcomes
* Age - Younger people generally have better survival rates
* Presence of B symptoms (fever, night sweats, weight loss)
* Treatment response - How well the lymphoma responds to therapy
For aggressive T-cell lymphomas specifically, treatment advances continue to improve outcomes. Stem cell transplantation can help in relapsed or refractory cases, and newer therapies like 3D conformal radiation therapy are being used for resistant cases.
It's important to discuss your individual prognosis with your healthcare team, as they can evaluate your specific risk factors and stage to provide a more personalized outlook. New treatments being developed may offer improved outcomes beyond current statistics.
April 2
Join
Your Privacy Choices
